Alliancebernstein L.P. Atri Cure, Inc. Transaction History
Alliancebernstein L.P.
- $280 Billion
- Q4 2024
A detailed history of Alliancebernstein L.P. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 3,835,449 shares of ATRC stock, worth $152 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,835,449
Previous 3,972,448
3.45%
Holding current value
$152 Million
Previous $111 Million
5.23%
% of portfolio
0.04%
Previous 0.04%
Shares
24 transactions
Others Institutions Holding ATRC
# of Institutions
220Shares Held
49.1MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.65MShares$184 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$183 Million0.0% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$112 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.53MShares$100 Million0.51% of portfolio
-
Macquarie Group LTD Australia, C32.38MShares$94.4 Million0.07% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.84B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...